Several MR-biomarkers characterizing different aspects of NAFLD progression, especially for the early onset, and late stages, are available. However, there is a need to combine and characterize, not only the endpoints but also the intermediate stages of the disease, in particular the early stages of hepatic inflammation. Using an extensive multi-modal MRI protocol, we have investigated correlations between different MR-biomarkers with histopathology measurements of hepatic inflammation, fat accumulation and fibrosis. The long-term aim of this research is to characterize each patient in the early to intermediate stages of disease progression, with a higher degree of precision.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords